NGM Biopharmaceuticals Price History

NGMDelisted Stock  USD 2.50  0.14  5.30%   
If you're considering investing in NGM Stock, it is important to understand the factors that can impact its price. As of today, the current price of NGM Biopharmaceutica stands at 2.50, as last reported on the 25th of November, with the highest price reaching 2.64 and the lowest price hitting 2.49 during the day. We have found twenty-four technical indicators for NGM Biopharmaceutica, which you can use to evaluate the volatility of the firm. Please verify NGM Biopharmaceutica's risk adjusted performance of (0.08), and Mean Deviation of 3.76 to check out if the risk estimate we provide is consistent with the expected return of 0.0%.
  
NGM Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
NGM
Based on monthly moving average NGM Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NGM Biopharmaceutica by adding NGM Biopharmaceutica to a well-diversified portfolio.

NGM Biopharmaceutica Stock Price History Chart

There are several ways to analyze NGM Stock price data. The simplest method is using a basic NGM candlestick price chart, which shows NGM Biopharmaceutica price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

NGM Stock Price History Data

The price series of NGM Biopharmaceutica for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 has a statistical range of 2.09 with a coefficient of variation of 15.62. The daily prices for the period are spread out with arithmetic mean of 3.34. The median price for the last 90 days is 3.33.
OpenHighLowCloseVolume
11/25/2024
 2.64  2.64  2.49  2.50 
07/24/2023 2.64  2.64  2.49  2.50  137,119 
07/21/2023 2.78  2.78  2.59  2.60  137,500 
07/20/2023 2.79  2.80  2.70  2.75  137,502 
07/19/2023 2.72  2.86  2.72  2.79  272,670 
07/18/2023 2.66  2.81  2.66  2.72  179,551 
07/17/2023 2.82  2.84  2.67  2.69  233,751 
07/14/2023 2.94  2.94  2.69  2.78  232,164 
07/13/2023 3.44  3.44  2.88  2.90  397,561 
07/12/2023 3.38  3.41  3.26  3.37  793,881 
07/11/2023 3.06  3.34  2.97  3.33  346,264 
07/10/2023 2.75  3.05  2.75  3.02  519,575 
07/07/2023 2.60  2.81  2.60  2.78  217,675 
07/06/2023 2.60  2.70  2.45  2.63  391,822 
07/05/2023 2.67  2.70  2.55  2.67  343,600 
07/03/2023 2.60  2.71  2.52  2.70  189,110 
06/30/2023 2.45  2.66  2.44  2.59  364,581 
06/29/2023 2.47  2.50  2.39  2.44  320,351 
06/28/2023 2.65  2.65  2.40  2.46  343,359 
06/27/2023 2.84  2.89  2.51  2.59  446,800 
06/26/2023 3.24  3.24  2.80  2.84  290,785 
06/23/2023 3.28  3.34  3.13  3.26  1,783,000 
06/22/2023 3.28  3.33  3.19  3.32  269,100 
06/21/2023 3.29  3.37  3.20  3.29  389,500 
06/20/2023 3.34  3.39  3.20  3.31  460,828 
06/16/2023 3.61  3.62  3.34  3.34  615,782 
06/15/2023 3.47  3.60  3.44  3.54  481,100 
06/14/2023 3.59  3.75  3.47  3.47  397,756 
06/13/2023 3.44  3.58  3.42  3.57  207,316 
06/12/2023 3.40  3.47  3.32  3.42  227,400 
06/09/2023 3.44  3.69  3.40  3.41  213,393 
06/08/2023 3.67  3.75  3.33  3.44  371,600 
06/07/2023 3.65  3.75  3.58  3.73  246,039 
06/06/2023 3.44  3.63  3.35  3.62  266,150 
06/05/2023 3.24  3.44  3.24  3.41  158,559 
06/02/2023 3.11  3.27  3.05  3.25  183,500 
06/01/2023 3.06  3.26  2.99  3.10  304,400 
05/31/2023 2.98  3.08  2.95  3.03  694,025 
05/30/2023 3.17  3.23  2.84  2.98  347,842 
05/26/2023 3.12  3.21  3.10  3.17  132,608 
05/25/2023 3.32  3.32  3.10  3.14  169,836 
05/24/2023 3.45  3.45  3.17  3.32  195,471 
05/23/2023 3.35  3.55  3.34  3.41  154,100 
05/22/2023 3.31  3.47  3.31  3.35  166,840 
05/19/2023 3.25  3.36  3.20  3.31  257,494 
05/18/2023 3.27  3.33  3.11  3.14  241,434 
05/17/2023 3.22  3.31  3.14  3.25  392,240 
05/16/2023 3.28  3.28  3.03  3.22  360,153 
05/15/2023 3.49  3.67  3.31  3.33  365,748 
05/12/2023 3.80  3.84  3.36  3.49  298,452 
05/11/2023 3.68  3.80  3.62  3.76  193,450 
05/10/2023 3.79  3.91  3.52  3.69  271,391 
05/09/2023 3.81  3.81  3.52  3.74  286,374 
05/08/2023 4.07  4.07  3.76  3.83  218,796 
05/05/2023 3.89  4.19  3.88  4.08  256,769 
05/04/2023 3.89  3.97  3.78  3.94  171,583 
05/03/2023 4.00  4.13  3.81  3.90  288,445 
05/02/2023 4.48  4.53  3.82  3.83  240,267 
05/01/2023 4.46  4.69  4.09  4.53  235,410 
04/28/2023 4.23  4.54  4.23  4.51  257,361 
04/27/2023 4.15  4.23  4.05  4.21  502,163 

About NGM Biopharmaceutica Stock history

NGM Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NGM is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NGM Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NGM Biopharmaceutica stock prices may prove useful in developing a viable investing in NGM Biopharmaceutica
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. NGM Biopharmaceuticals, Inc. was incorporated in 2007 and is headquartered in South San Francisco, California. Ngm Biopharmaceutica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 225 people.

NGM Biopharmaceutica Stock Technical Analysis

NGM Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of NGM Biopharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of NGM Biopharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Earnings Calls Now

   

Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges
All  Next Launch Module

NGM Biopharmaceutica Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for NGM Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of NGM Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NGM to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in NGM Stock

If you are still planning to invest in NGM Biopharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the NGM Biopharmaceutica's history and understand the potential risks before investing.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated